TopNews

A study published in the JAMA Internal Medicine has found that vitamin D supplements have not been found effective in reducing blood pressure. Therefore, the research team recommends that it should not be used as an antihypertensive agent.

The study findings have challenged the earlier suggestions that the vitamin D could be used as treatment for high blood pressure. The researchers have conducted a review of trials and patients.

Study's lead researcher Dr. Miles Witham, of the School of Medicine at Dundee, Scotland, affirmed that large-scale studies have shown that people with low vitamin D levels have more chances to have higher blood pressure.

Electric vehicle market Tesla Motors said it is updating its Model S electric car with an aim to help ease drivers' concerns about running out of battery charge.

Tesla also hinted that in near future, drivers can take their hands off the wheel altogether. Latest update of Tesla will plan the best route to a destination driver's based on the location of charging stations. Tesla said that it will guide the car to available spots to charge.

The car will give warning to drivers if battery power is low before they drive beyond an area where they can charge. Tesla first achieved widespread attention following their production of the Tesla Roadster, which is the first fully electric sports car. Tesla’s second vehicle is the Model S, which is a completely electric luxury sedan.

Ryanair Ltd., an Irish low-cost airline, on Thursday announced that it made a mistake in announcing that its board had agreed on the plans to expand to North America.

The mistaken announcement by the airlines doesn’t end there as while making that apparently erroneous statement on Monday, Ryanair went quite far saying that it might sell its cheapest seats on those routes for £10.

Ryanair in a formal recantation said, “In the light of recent press coverage, the Board of Ryanair Holdings Plc wishes to clarify that it has not considered or approved any transatlantic project and does not intend to do so”.

Michael O'Leary, Ryanair's frequently outspoken CEO said in a statement that the entire announcement made on Monday was a sheer miscommunication.

On Thursday, athletic-gear maker Nike reported a 7% jump in revenue and 16% jump in income for the fiscal third quarter that ended on February 28.

The Beaverton Oregon-based company said that sales were up sharply in the North American market and key foreign markets despite stronger dollar, which makes Nike's products more expensive in other currencies.

The company also mentioned that it invested more money in its business and effective tax rates increased. The company’s net income totaled $791 million, or 89 cents per share, from $682 million, or 75 cents per share. Its revenue grew 75 to $7.46 billion from $6.97 billion.

According to Zacks Investment Research, analysts expected income of 84 cents per share and $7.64 billion in revenue.

As per researchers from the University of Michigan, women who sleep more generally have more sex. The researchers have spent more than two weeks in tracking sleep and sexual patterns of 171 young women.

The researchers found two things. Firstly, more shut-eye generally leads to more sex among women. Secondly, it also leads to better sex. The researchers said good sleep hygiene refreshes a person’s mood, energy and concentration.

It is linked to increased sexual desire and arousal. The participants reported high physical arousal after having longer period of sleep, with average sleep duration to be seven hours, 22 minutes. The researchers said that what was most impressive, every additional hour of sleep increased the chances of sex on the next day by 14%.

On Thursday, an advisory panel to the United States Food and Drug Administration stated that British multinational pharmaceutical company GlaxoSmithKline Plc's asthma drug to treat chronic breathing problems is safe for adults. The panel also warned that the drug is not effective for adolescents with asthma.

According to reports, the panel voted 16-4. As per panel, the drug should be approved for once daily treatment of asthma in patients 18 years and older. The panel also voted 19-1 and concluded that drug will not be approved for children aged 12 to 17. Glaxo, which is headquartered in Brentford, licensed the product from Theravance Inc in 2002.